Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

OBJECTIVE: To compare the efficacy and adverse effects of paclitaxel-etoposide-carboplatin/cisplatin (TEP/TCE) regimen with those of etoposide-carboplatin/cisplatin (EP/CE) regimen as first-line treatment for combined small-cell lung cancer (CSCLC). METHODS: A retrospective study was conducted on 62...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Biol Med
Hlavní autoři: Li, Yue-Ya, Zhou, Chan, Yang, Deng-Xia, Wang, Jing, Liu, Zhu-Jun, Wang, Xin-Yue, Li, Kai
Médium: Artigo
Jazyk:Inglês
Vydáno: Chinese Anti-Cancer Association 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493380/
https://ncbi.nlm.nih.gov/pubmed/26175927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7497/j.issn.2095-3941.2015.0012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky